Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s.
Acta Pharmacol Sin. 2022 Jun;43(6):1495-1507. doi: 10.1038/s41401-021-00781-7. Epub 2021 Oct 20. Acta Pharmacol Sin. 2022. PMID: 34671110 Free PMC article.